Results 131 to 140 of about 3,343,278 (165)

Motor cortex in levodopa-induced dyskinesia: Systems and molecular changes after sub-anesthetic ketamine treatment. [PDF]

Neural Regen Res
Falk T, Cowen SL.
europepmc   +1 more source

Recent and on-going trials for the treatment of levodopa-induced dyskinesia: a review of the clinical trial databases. [PDF]

Neurodegener Dis Manag
Al-Kassmy J, Alsalmi M, Kang W, Palayew M, Huot P.   +4 more
europepmc   +1 more source

Neurophysiological Treatment Effects of Mesdopetam, Pimavanserin and Amantadine in a Rodent Model of Levodopa-Induced Dyskinesia. [PDF]

Eur J Neurosci
Ronaghi A, Stan TL, Barrientos SA, Halje P, Nasretdinov A, Censoni L, Sato SS, Malinina E, Tedroff J, Waters N, Petersson P.   +10 more
europepmc   +1 more source

Levodopa-induced dyskinesia alters postural control in people with Parkinson's disease. [PDF]

J Biomech
Aderonmu JA, Curtze C.
europepmc   +1 more source

Levodopa-induced dyskinesia is still a major clinical problem in Brazilian movement disorder clinics. [PDF]

Arq Neuropsiquiatr
Tumas V, Brito MMCM, Borges V, Ferraz HB, Zabetian CP, Mata IF, Santos-Lobato BL.   +6 more
europepmc   +1 more source

Electrophysiological Alterations in the Progression of Parkinson's Disease and the Therapeutic Effect of Tetrabenazine on Rats With Levodopa-Induced Dyskinesia. [PDF]

CNS Neurosci Ther
Bi Y, Wang P, Li M, Wang Z, Lv S, Yang Y, Zhang W.   +6 more
europepmc   +1 more source

Mesdopetam for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease: A Randomized Phase 2b Trial. [PDF]

Mov Disord Clin Pract
Antonini A, O'Suilleabhain P, Stocchi F, Landström J, Waters S, Sonesson C, Tedroff J.   +6 more
europepmc   +1 more source

Dopamine Pathway and Parkinson's Risk Variants Are Associated with Levodopa-Induced Dyskinesia. [PDF]

Mov Disord
Sosero YL, Bandres-Ciga S, Ferwerda B, Tocino MTP, Belloso DR, Gómez-Garre P, Gómez-Garre P, Faouzi J, Taba P, Pavelka L, Marques TM, Gomes CPC, Kolodkin A, May P, Milanowski LM, Wszolek ZK, Uitti RJ, Heutink P, van Hilten JJ, Simon DK, Eberly S, Alvarez I, Krohn L, Yu E, Freeman K, Rudakou U, Ruskey JA, Asayesh F, Menéndez-Gonzàlez M, Pastor P, Ross OA, Krüger R, NCER‐PD Consortium, Corvol JC, Koks S, Mir P, De Bie RMA, Iwaki H, Gan-Or Z, International Parkinson's Disease Genomic Consortium.   +39 more
europepmc   +1 more source

Functional motor network abnormalities associated with levodopa-induced dyskinesia in Parkinson's disease: A systematic review. [PDF]

Neuroimage Clin
Chen Thomsen BL, Vinding MC, Meder D, Marner L, Løkkegaard A, Siebner HR.   +5 more
europepmc   +1 more source

Baseline [¹⁸F]FP-CIT PET-based deep learning prediction of levodopa-induced dyskinesia in Parkinson's disease. [PDF]

NPJ Parkinsons Dis
Lee GY, Won J, Kim S, Jo S, Lee J, Lee S, Kim JS, Sung C, Oh JS, Kim J, Kim N, Chung SJ.   +11 more
europepmc   +1 more source